Back to results
US 2025/0019379 A1Published application
New crystal form of compound, and preparation method therefor and use thereof
AssigneeE-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd
InventorsPengfei LIU, Wang SHEN, Hongjun GAO, Shizhe DING
Life of this patent
Estimating the term…
Abstract
Provided are a crystal form of a compound of formula (I), a method for preparing the crystal form, a pharmaceutical composition containing the crystal form, and the use thereof in the preparation of a drug for treating diseases, disorders or symptoms, or a method thereof for treating diseases, disorders or symptoms.
Claims21
A crystalline form A of the compound of formula (I),
- wherein the X-ray powder diffraction pattern comprises characteristic peaks at 2θ angles of 8.6°±0.2°, 9.8°±0.2°, 10.7°±0.2°, 11.2°±0.2°, 12.3°±0.2°, 12.9°±0.2°, 16.0°±0.2°, and 19.0°±0.2°.
A crystalline form Q of the compound of formula (I),
- wherein the X-ray powder diffraction pattern comprises characteristic peaks at 2θ angles of 8.5°±0.2°, 14.5°±0.2°, 15.0°±0.2°, 16.8°±0.2°, 19.4°±0.2°, 23.6°±0.2°, 24.8°±0.2°, 26.3°±0.2°, and 27.4°±0.2°.
11-16. (canceled)
Dependencies are inferred from the claim text.